XENE- Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. XENE is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 30.0K | $1.63M | - | |
| Other | 20.0K | $1.09M | - | |
| CEO | 19.9K | $1.09M | - | |
| Other | 7.3K | $397.8K | - | |
| Other | 7.1K | $385.2K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Difabio Andrea | Chief Legal Officer | Sale+OE | 1,342 | $55.22 | $74,111.95 | -15.5% | -5.5% | - | |
| Mar 13, 2026 | Mortimer Ian57 | President &CEO | Sale+OE | 7,308 | $55.23 | $403,584.30 | -26.8% | -5.5% | - | |
| Mar 13, 2026 | Kenney Christopher John56 | Chief Medical Officer | Sale+OE | 1,410 | $55.23 | $77,867.25 | -16.6% | -5.5% | - | |
| Mar 10, 2026 | Difabio Andrea | Chief Legal Officer | Sale+OE | 2,607 | $60.11 | $156,701.56 | -34.8% | -11.7% | - | |
| Mar 10, 2026 | Mortimer Ian57 | President &CEO | Sale+OE | 281,269 | $60.32 | $16,966,499.55 | -55.5% | -11.7% | - | |
| Mar 10, 2026 | Kenney Christopher John56 | Chief Medical Officer | Sale+OE | 2,771 | $60.11 | $166,559.27 | -36.9% | -11.7% | - | |
| Jan 2, 2026 | Mortimer Ian57 | President &CEO | Sale+OE | 40,000 | $44.43 | $1,777,092.86 | -74.0% | +27.8% | - | |
| Dec 8, 2025 | Mortimer Ian57 | President &CEO | Sell | 25,205 | $45.33 | $1,142,513.25 | -45.0% | +40.8% | - | |
| Nov 28, 2025 | Mortimer Ian57 | President &CEO | Sell | 97 | $45.01 | $4,365.97 | -0.3% | +0.3% | - | |
| Oct 1, 2025 | Mortimer Ian57 | President, CEO &Interim CFO | Sale+OE | 25,000 | $40.16 | $1,004,000.00 | -44.4% | +12.8% | - |
Page 1Next →